Abstract
Nanophotonic platforms in theory uniquely enable < femtomoles of chiral biological and pharmaceutical molecules to be detected, through the highly localised changes in the chiral asymmetries of the near-fields that they induce. However, current chiral nanophotonic based strategies are intrinsically limited because they rely on far-field optical measurements that are sensitive to a much larger near-field volume, than that influenced by the chiral molecules. Consequently, they depend on detecting small changes in far-field optical response restricting detection sensitivities. Here we exploit an intriguing phenomenon, plasmonic circularly polarised luminescence (PCPL), which is an incisive local probe of near-field chirality. This allows chiral detection of monolayer quantities of a de novo designed peptide, which is not achieved with a far-field response. Our work demonstrates that by leveraging the capabilities of nanophotonic platforms with the near-field sensitivity of PCPL, optimal biomolecular detection performance can be achieved, opening new avenues for nanometrology.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.